EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Resolution of dysglycaemia after treatment of monoclonal gammopathy of endocrine significance

Bonnie Grant iD, Gowri Ratnayake, Claire L Williams, Anna Long iD, David J Halsall, Robert K Semple iD, James D Cavenagh, William M Drake, David S Church iD

European Journal of Endocrinology · 06.12.2023 · 189 (6) · K25-K29

DOI: 10.1093/ejendo/lvad138 ↗

Kurz gefasst

Fallbericht in der Zeitschrift European Journal of Endocrinology, online erschienen am 11.10.2023. Verfasst von Bonnie Grant und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, St Bartholomew's Hospital, Barts Health NHS Trust, London EC1A 7BE, United Kingdom. Hauptthemen laut MEDLINE: Monoclonal Gammopathy of Undetermined Significance, Paraproteinemias, Endocrine System Diseases, Hypoglycemia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In very rare cases of monoclonal gammopathy, insulin-binding paraprotein can cause disabling hypoglycaemia. We report a 67-year-old man re-evaluated for hyperinsulinaemic hypoglycaemia that persisted despite distal pancreatectomy. He had no medical history of diabetes mellitus or autoimmune disease but was being monitored for an IgG kappa monoclonal gammopathy of undetermined significance. On glucose tolerance testing, hyperglycaemia occurred at 60 min (glucose 216 mg/dL) and hypoglycaemia at 300 min (52 mg/dL) concurrent with an apparent plasma insulin concentration of 52 850 pmol/L on immunoassay. Laboratory investigation revealed an IgG2 kappa with very high binding capacity but low affinity (Kd 1.43 × 10−6 mol/L) for insulin. The monoclonal gammopathy was restaged as smouldering myeloma not warranting plasma cell–directed therapy from a haematological standpoint. Plasma exchange reduced paraprotein levels and improved fasting capillary glucose concentrations. Lenalidomide was used to treat disabling hypoglycaemia, successfully depleting paraprotein and leading to resolution of symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Monoclonal Gammopathy of Undetermined SignificanceParaproteinemiasEndocrine System DiseasesHypoglycemiaMultiple MyelomaMaleHumansAgedParaproteinsInsulinGlucose

Stichwörter der Autor:innen

MGUShyperinsulinaemiahypoglycaemiainsulin autoantibodieslenalidomidemyelomaplasma exchangesmouldering myeloma

Substanzen

ParaproteinsInsulinGlucose

Autor:innen und Institutionen

  • Department of Endocrinology, St Bartholomew's Hospital, Barts Health NHS Trust, London EC1A 7BE, United Kingdom.
  • Translational Health Sciences, Bristol Medical School, University of Bristol, Learning and Research, Southmead Hospital, Bristol BS10 5NB, United Kingdom.
  • Department of Clinical Biochemistry and Immunology, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, United Kingdom.
  • Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom.
  • MRC Human Genetics Unit, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh EH4 2XU, United Kingdom.
  • Department of Haematolo-Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London EC1A 7BE, United Kingdom.

ORCID-Profile: Bonnie Grant, Anna Long, Robert K Semple, David S Church

Förderung

  • Wellcome Trust

Zitieren

APA

Grant, B., Ratnayake, G., Williams, C. L., Long, A., Halsall, D. J., Semple, R. K., Cavenagh, J. D., Drake, W. M., & Church, D. S. (2023). Resolution of dysglycaemia after treatment of monoclonal gammopathy of endocrine significance. European Journal of Endocrinology, 189(6), K25-K29. https://doi.org/10.1093/ejendo/lvad138

Vancouver

Grant B, Ratnayake G, Williams CL, Long A, Halsall DJ, Semple RK, et al. Resolution of dysglycaemia after treatment of monoclonal gammopathy of endocrine significance. European Journal of Endocrinology. 2023;189(6):K25-K29. doi:10.1093/ejendo/lvad138

BibTeX
@article{Grant2023,
  author = {Grant, Bonnie and Ratnayake, Gowri and Williams, Claire L and Long, Anna and Halsall, David J and Semple, Robert K and Cavenagh, James D and Drake, William M and Church, David S},
  title = {Resolution of dysglycaemia after treatment of monoclonal gammopathy of endocrine significance},
  journal = {European Journal of Endocrinology},
  year = {2023},
  volume = {189},
  number = {6},
  pages = {K25--K29},
  doi = {10.1093/ejendo/lvad138}
}
Kostenlos starten →